Author:
Fontana Camilla,Marasca Federica,Provitera Livia,Mancinelli Sara,Pesenti Nicola,Sinha Shruti,Passera Sofia,Abrignani Sergio,Mosca Fabio,Lodato Simona,Bodega Beatrice,Fumagalli Monica
Abstract
Abstract
Background
Preterm birth affects almost 9–11% of newborns and is one of the leading causes of childhood neurodevelopmental disabilities; the underlying molecular networks are poorly defined. In neurons, retrotransposons LINE-1 (L1) are an active source of genomic mosaicism that is deregulated in several neurological disorders; early life experience has been shown to regulate L1 activity in mice.
Methods
Very preterm infants were randomized to receive standard care or early intervention. L1 methylation was measured at birth and at hospital discharge. At 12 and 36 months, infants’ neurodevelopment was evaluated with the Griffiths Scales. L1 methylation and CNVs were measured in mouse brain areas at embryonic and postnatal stages.
Results
Here we report that L1 promoter is hypomethylated in preterm infants at birth and that an early intervention program, based on enhanced maternal care and positive multisensory stimulation, restores L1 methylation levels comparable to healthy newborns and ameliorates neurodevelopment in childhood. We further show that L1 activity is fine-tuned in the perinatal mouse brain, suggesting a sensitive and vulnerable window for the L1 epigenetic setting.
Conclusions
Our results open the field on the inspection of L1 activity as a novel molecular and predictive approach to infants’ prematurity-related neurodevelopmental outcomes.
Trial registration
ClinicalTrial.gov (NCT02983513). Registered on 6 December 2016, retrospectively registered.
Funder
Ministero della Salute
Università degli Studi di Milano
Regione Lombardia
Fondazione Cariplo
Publisher
Springer Science and Business Media LLC
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献